Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery
Comunicato Precedente
Comunicato Successivo
Qiming Venture Partners expresses our condolences to the families impacted by the major fire, and our deepest respect to the firefighters and rescue personnel at the frontline. We are grateful for their exceptional professionalism and selfless dedication which were evident throughout the crisis. Qiming hopes that its contribution will help alleviate the challenges faced by affected residents and support their swift return to normal life. Qiming also calls on more social forces to join in the relief efforts and contribute to the rebuilding of the affected communities.
About Qiming Venture Partners
Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.
Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.
Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, HESAI, UBTech, WeRide, HyperStrong, Insta360, Unisound, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, AusperBio, Yuanxin Technology, Insilico Medicine, Medilink Therapeutics, LaNova Medicines, zai, StepFun, among many others.
View original content:https://www.prnewswire.co.uk/news-releases/qiming-venture-partners-donates-hk3-million-to-tai-po-wang-fuk-court-aid-fund-for-post-fire-recovery-302628530.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




